This supports the idea that the C/T mutation in 3′UTR might have an oncogenic effect because it might increase the expression of the oncogene gene SLC35F2, providing some hypothesis that UTR mutation might be involved in cancer progression. The gene discussed is SLC35F2; the disease is cancer.